.noscriptmsg { font-size: 20px; color: red; }

JavaScript is disabled. Please enable to continue!

Eurofins >> Medical Device >> Webinars & Events >> Webinars & Seminars >> CE/MDR versus FDA submission: Biocompatibility requirements. Differences, Challenges & pitfalls

Webinars & Events >> Webinars & Seminars >> CE/MDR versus FDA submission: Biocompatibility requirements. Differences, Challenges & pitfalls

CE/MDR versus FDA submission: Biocompatibility requirements. Differences, Challenges & pitfalls

In May 2021 the Medical Device Regulation (MDR) came into effect and the U.S. Food and Drug Administration (FDA) published the updated guidance for biocompatibility assessment of medical devices in September 2023.

In this webinar, we will explore the essential aspects of biocompatibility assessment and especially the differences to meet regulatory compliance in Europe and for the US FDA.

Our speaker will provide valuable insights and practical guidance to help you ensure that your medical devices meet the necessary biocompatibility standards for market approval.

Recording request

Fill in the form to request your webinar recording.
Please be sure not to use accented letters as they are not recognised by the system.

Please enter this field. Maximum character limit is 30.

Please enter this field. Enter valid Phone Number with format (Country Code-Phone Number) Phone number cannot exceed more than 20 digits.

Please enter this field. Enter a valid Email Address.

Please enter this field. Maximum allowed characters is 5000.

+ Attach A File Allowed file size for upload is 2 MB. Allowed file types : doc,docx & pdf.

I agree to the Privacy policy

Please accept the privacy policy .

Please fill Captcha

Something went wrong. Please try again later. Invalid text in the fields.

Thank you for contacting our Team

Back to Webinars & Seminars